Cumberland Pharmaceuticals (CPIX) Tops Q2 EPS by 15c

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.08, $0.15 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $8.57 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• 'We expect salesforce.com (CRM) to capture a meaningful share of next-gen agentic workflows': Cantor
• Jefferies Downgrades Sunway Healthcare Holdings (SUNMED:MK) to Hold